阴道镜下隐匿性子宫颈上皮内瘤变Ⅲ级的特征
基于深圳子宫颈癌筛查项目Ⅱ中93例CINⅢ患者的169个象限组织,分析阴道镜下隐匿CINⅢ的HPV分型与鳞状上皮厚度特征。隐匿CINⅢ的HPV16阳性率低于可见CINⅢ,且鳞状上皮更薄;非HPV16阳性者年龄≥45岁比例更高、病灶>1个象限比例更低。
要点
- 隐匿CINⅢ的HPV16阳性率为37.2%(16/43),低于可见CINⅢ的55.6%(70/126)。
- 可见CINⅢ鳞状上皮厚度(161±9)μm,厚于隐匿CINⅢ的(140±12)μm。
- 非HPV16阳性者年龄≥45岁比例40.9%(18/44),高于HPV16阳性者的20.4%(10/49)。
核心结论
- 阴道镜下隐匿CINⅢ不易识别,可能与非HPV16型阳性、病灶范围小、病灶鳞状上皮较薄有关。
- 对非HPV16型阳性及年龄偏大者行阴道镜检查时,通过在子宫颈转化区域行病灶活检及多点随机活检,可能有助于提高CINⅢ检出率、减少漏诊率。
研究设计与样本
- 从2009至2010年深圳子宫颈癌筛查项目Ⅱ(SHENCCAST Ⅱ)中提取93例最终诊断为CINⅢ患者的169个象限活检组织。
- 石蜡标本按三明治法重新制作6张连续切片,首末两张HE染色明确诊断,第3至5张共3张白片以基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)法行HPV分型检测,显微镜(×10)下测量CINⅢ病变鳞状上皮厚度。
- 阴道镜指示对可见病灶活检发现的CINⅢ定义为可见CINⅢ,子宫颈随机多点活检发现的CINⅢ定义为隐匿CINⅢ。
主要发现
- 169个象限中43个为隐匿CINⅢ、126个为可见CINⅢ,HPV16阳性率分别为37.2%(16/43)和55.6%(70/126),差异有统计学意义(χ²=4.318,P=0.038)。
- 93例CINⅢ患者中HPV16阳性49例、非HPV16阳性44例,年龄≥45岁者比例分别为20.4%(10/49)和40.9%(18/44),差异有统计学意义(χ²=4.630,P=0.031)。
- CINⅢ病灶>1个象限者比例在HPV16阳性组为79.6%(39/49),高于非HPV16阳性组的52.3%(23/44),差异有统计学意义(χ²=7.786,P=0.005)。
- 可见CINⅢ鳞状上皮厚度为(161±9)μm,厚于隐匿CINⅢ的(140±12)μm,差异有统计学意义(t=4.383,P=0.038)。
- HPV16阳性者CINⅢ鳞状上皮厚度为(172±11)μm,厚于非HPV16阳性者的(130±10)μm,差异有统计学意义(t=4.784,P=0.031)。
临床怎么用
- 作者认为,对非HPV16型阳性或年龄偏大者行阴道镜检查时,通过在子宫颈转化区域行病灶活检及多点随机活检,可能有助于提高CINⅢ检出率、减少漏诊率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the human papilomavirus (HPV) genotypes and epithelial thickness of invisible cervical intraepithelial neoplasia Ⅲ (CIN Ⅲ) under colposcopy. Methods: One hundred and sixty-nine biopsies from 93 patients with a final diagnosis of CIN Ⅲ were extracted from the Shenzhen cervical cancer screening trial Ⅱ (SHENCCAST Ⅱ) . The SHENCCAST Ⅱ was conducted from 2009 to 2010. All the cervical blocks from these patients were re-cut and placed on 6 slides, i.e. sandwich model, with the top and bottom sections being stained with HE, the top second be processed for other studies, 3 sections for HPV genotypes by matrix-assisted laser desorption ionization-time of flight-mass spectrometry (MALDI-TOF-MS) assay. The thickness of squamous epithelium of CIN Ⅲ was measured by a microscope (×10) after re-cut. Colposcope directed CIN Ⅲ biopsies positively was defined as visible CIN Ⅲ, while random CIN Ⅲ biopsies positively was defined as invisible CIN Ⅲ. Results: HPV16 positivity was 37.2% (16/43) and 55.6% (70/126) between invisible and visible CIN Ⅲ biopsies, respectively (χ(2)=4.318, P=0.038) . Forty-nine cases of the 93 CIN Ⅲ patients were HPV16 positive, while 44 of them non-HPV16 positive. The proportion of patients with ≥45 years of age for other non-HPV16 positive 40.9% (18/44) was significantly higher than that HPV16 positive 20.4% (10/49; χ(2)=4.630, P=0.031) . Patients with HPV16 positive were more likely to have lesions ≥1 quadrant (χ(2)=7.786, P=0.005) than other non-HPV16 positive. Compared the average epithelium thickness of invisible CIN Ⅲ tissue (140±12) μm, the average epithelium thickness of visible CIN Ⅲ tissue (161±9) μm was thicker. There was statistical difference between two groups (t=4.383, P=0.038). The mean average epithelial thickness of CIN Ⅲ with HPV16 positive (172±11) μm was thicker than that the mean average epithelial thickness of CIN Ⅲ with non-HPV16 positive (130±10) μm (t=4.784, P=0.031) . Conclusions: Invisible lesions is difficult to identify under colposcopy and is related to non-HPV16 positive, small lesion size and thinner squamous epithelium. For non-HPV16 positive or older women should be performed colposcope directed biopsies and randomly multi-sites biopsies by colopscopy, which may be helpful to improve the detection of CIN Ⅲ and to reduce miss diagnosis. 目的: 探讨阴道镜下隐匿子宫颈上皮内瘤变Ⅲ级(CINⅢ)病变的HPV亚型感染特征及鳞状上皮厚度。 方法: 对2009—2010年期间进行的深圳子宫颈癌筛查项目Ⅱ(SHENCCAST Ⅱ)研究中有完整资料、病理诊断为CINⅢ的93例患者的169个象限的CINⅢ组织的石蜡标本采用"三明治"法重新制作6张连续切片,其中第1张和最后1张行HE染色以明确病理诊断并确保其间的切片中含有同样级别的病变,第3~5张(第2张用于其他研究)共3张白片用于行基质辅助激光解吸电离飞行时间质谱(MALDI-TOF-MS)法HPV分型检测,并在显微镜下(×10)对CINⅢ病变部位的鳞状上皮厚度进行测量。其中,由阴道镜指示对可见病灶进行活检发现的CINⅢ定为"可见CINⅢ",通过子宫颈随机多点活检发现的CINⅢ定为"隐匿CINⅢ"。 结果: (1)169个象限中,43个象限为隐匿CINⅢ、126个象限为可见CINⅢ,其HPV16型阳性率分别为37.2%(16/43)和55.6%(70/126),两者比较,差异有统计学意义(χ(2)=4.318,P=0.038)。93例CINⅢ患者中,HPV16型阳性和非HPV16型阳性患者分别为49和44例,其中年龄≥45岁患者所占比例分别为20.4%(10/49)和40.9%(18/44),两者比较,差异有统计学意义(χ(2)=4.630,P=0.031);CINⅢ病灶>1个象限患者所占比例分别为79.6%(39/49)和52.3%(23/44),两者比较,差异也有统计学意义(χ(2)=7.786,P=0.005)。(2)阴道镜下可见CINⅢ病变的鳞状上皮厚度为(161±9)μm,较隐匿CINⅢ病变者[(140±12)μm]厚,两者比较,差异有统计学意义(t=4.383,P=0.038)。HPV16型阳性与非HPV16型阳性患者的CINⅢ病变的鳞状上皮厚度分别为(172±11)和(130±10)μm,两者比较,差异有统计学意义(t=4.784,P=0.031)。 结论: 阴道镜下隐匿CINⅢ不易识别,可能与非HPV16型阳性、病灶范围小、病灶的鳞状上皮较薄有关。对非HPV16型阳性及年龄偏大者行阴道镜检查时,通过在子宫颈转化区域行病灶活检及多点随机活检,可提高CINⅢ的检出率,减少漏诊率。.
引用
- Chen Q, Du H, Wang C, et al. [Characteristics of invisible cervical intraepithelial neoplasia Ⅲ under colposcopy]. Zhonghua Fu Chan Ke Za Zhi. 2018. PMID: 29609231. doi:10.3760/cma.j.issn.0529-567X.2018.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。